If you have signs of coronary artery disease, the HeartFlow Analysis can help provide answers.
Despite many recent advances in cardiovascular diagnosis and treatment, misdiagnosis is still a common concern for patients at risk of heart disease, the leading cause of death in the United States. A complex web of symptoms, circumstances and comorbidities means that it’s not always easy for physicians to correctly identify conditions on the first visit.
Despite many recent advances in cardiovascular diagnosis and treatment, misdiagnosis is still a common concern for patients at risk of heart disease, the leading cause of death in the United States. A complex web of symptoms, circumstances and comorbidities means that it’s not always easy for physicians to correctly identify conditions on the first visit.
Kavitha Chinnaiyan, M.D.,
Dir. of Cardiac Imaging Research,
William Beaumont Hospital
Applying advanced technologies
Read a perspective from Dr. Robert Safian, Interventional Cardiologist, on how faster turnaround times have allowed his organization to bring HeartFlow to the Emergency Department – deep learning algorithms are helping.
Applying advanced technologies
Read a perspective from Dr. Robert Safian, Interventional Cardiologist, on how faster turnaround times have allowed his organization to bring HeartFlow to the Emergency Department – deep learning algorithms are helping.
This would be a caption under the image or video
This would be a caption under the image or video
“After being with my wife during her experience, I knew that I needed to take my own issues seriously.”
“After being with my wife during her experience, I knew that I needed to take my own issues seriously.”
“After being with my wife during her experience, I knew that I needed to take my own issues seriously.”
“After being with my wife during her experience, I knew that I needed to take my own issues seriously.”
“After being with my wife during her experience, I knew that I needed to take my own issues seriously.”
Note:
The header, footer, and page title above are also saved as reusable templates. They are called “Heartflow Header”, “Heartflow Footer”, and “PageTitle”, respectively.
Templates created but not included here visually include:
– Error 404 (appears only on 404 pages)
– Standard Contact Form Popup (for use when in need of a contact form popup or onclick lightbox)
Additional Notes: Some templates are included inside others, as noted below. All headlines below are the template name. To use in Elementor, you may use the shortcodes found in Templates->Saved Templates->All, or you can choose “template” when adding an elementor block, then search by the name. All custom/additional CSS is found in Themes->Customize->Additional CSS. This should be moved eventually to style.css in the child theme, but have left it here for the time being because it breaks cache when you save, so you can see change immediately. Style.css often caches.
“After being with my wife during her experience, I knew that I needed to take my own issues seriously.”
“After being with my wife during her experience, I knew that I needed to take my own issues seriously.”
“After being with my wife during her experience, I knew that I needed to take my own issues seriously.”
“After being with my wife during her experience, I knew that I needed to take my own issues seriously.”
“After being with my wife during her experience, I knew that I needed to take my own issues seriously.”
The information provided by the HeartFlow Analysis is intended to be used in conjunction with the patient’s clinical history, symptoms, and other diagnostic tests, as well as the clinician’s professional judgement. The HeartFlow Analysis may not be appropriate for all patients. See indications for use for more information. The HeartFlow Analysis, featuring FFRCT Analysis, RoadMapTM Analysis and Plaque Analysis is commercially available in the United States. The FFRCT Analysis is commercially available in Europe, Japan, Canada and the United Kingdom. The FFRCT Analysis is also commercially available in Europe, Japan, and Canada.
© 2024 HeartFlow, Inc. | HeartFlow and the HeartFlow logo are registered trademarks of HeartFlow, Inc. Additionally, RoadMap is claimed as a trademark of HeartFlow, Inc. www.heartflow.com | 331 E Evelyn Ave, Mountain View, CA 94041
*Required fields
If you would like to request to have the HeartFlow Analysis available at a location near you, please submit your information below with details of the institution. We will share this information with the institution, but it will not guarantee HeartFlow will become available.
*Required fields
オンライン提出フォームから研究助成金を申請してください。
HeartFlow FFRCT 分析は、有資格の臨床医による臨床的に安定した症状のある冠状動脈疾患患者への使用を目的とした個別化された心臓検査です。 HeartFlow Analysis によって提供される情報は、資格のある臨床医が患者の病歴、症状、その他の診断検査、および臨床医の専門的判断と組み合わせて使用することを目的としています。
ハートフロー分析に関する追加の適応情報については、次のサイトをご覧ください。www.heartflow.com/indications.
さらに質問がある場合は、このメッセージを閉じてフォームに記入するか、サポート チームにお電話ください。: 877.478.3569.
The HeartFlow FFRCT Analysis is a personalized cardiac test indicated for use in clinically stable symptomatic patients with coronary artery disease by qualified clinicians. The information provided by the HeartFlow Analysis is intended to be used by qualified clinicians in conjunction with the patient’s history, symptoms, and other diagnostic tests, as well as the clinician’s professional judgement.
For additional indication information about the HeartFlow Analysis, please visit www.heartflow.com/indications.
If you have additional questions, close out of this message to complete our form or call our support team: 877.478.3569.Please use our online submission form on the Clinical Research Page to apply for research grants.
Thank you for your interest!
Executive Vice President and Chief Medical Officer
Campbell brings a wealth of experience to HeartFlow, where he serves as the Chief Medical Officer. Prior to joining HeartFlow, he was the Chief Scientific Officer and Global Head of Research and Development at Cordis Corporation, Johnson & Johnson, where he was responsible for leading investments and research in cardiovascular devices. Prior to Cordis, he was Associate Professor of Medicine at Harvard Medical School and the Harvard-M.I.T. Division of Health Sciences and Technology, and Director of the Cardiac Catheterization and Experimental Cardiovascular Interventional Laboratories at Brigham and Women’s Hospital. He served as Principal Investigator for numerous interventional cardiology device, diagnostic, and pharmacology trials, is the author of numerous journal articles, chapters, and books in the area of coronary artery and other cardiovascular diseases, and was the recipient of research grant awards from the NIH and AHA.
He received his A.B. from Harvard College and his M.D. from Harvard Medical School.